Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Targeting the Calcium Signalling Machinery in Cancer
Jason I E Bruce1, Andrew D James2
1Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.
Abstract:
Cancer is caused by excessive cell proliferation and a propensity to avoid cell death, while the spread of cancer is facilitated by enhanced cellular migration, invasion, and vascularization. Cytosolic Ca2+ is central to each of these important processes, yet to date, there are no cancer drugs currently being used clinically, and very few undergoing clinical trials, that target the Ca2+ signalling machinery. The aim of this review is to highlight some of the emerging evidence that targeting key components of the Ca2+ signalling machinery represents a novel and relatively untapped therapeutic strategy for the treatment of cancer.
Insights
Targeting calcium signaling pathways offers a novel therapeutic strategy for cancer treatment. This approach addresses key cancer hallmarks like proliferation and migration, presenting a promising avenue for drug development.
Area of Science:
- Oncology
- Molecular Biology
- Calcium Signaling
Background:
- Cancer involves uncontrolled cell proliferation, evasion of cell death, and metastasis.
- Cytosolic calcium ions (Ca2+) play a critical role in these cancer-associated cellular processes.
- Current cancer therapies do not extensively target the Ca2+ signaling machinery.
Purpose of the Study:
- To review emerging evidence on targeting Ca2+ signaling components as a cancer treatment strategy.
- To highlight the therapeutic potential of modulating Ca2+ pathways in oncology.
Main Methods:
- Literature review of studies investigating the role of Ca2+ in cancer.
- Analysis of emerging therapeutic strategies targeting Ca2+ signaling pathways.
Main Results:
- Ca2+ signaling is integral to cancer cell proliferation, survival, migration, invasion, and vascularization.
- Modulating specific Ca2+ channels and pumps shows potential in preclinical cancer models.
- Targeting Ca2+ machinery represents an underexplored therapeutic avenue.
Conclusions:
- Targeting cytosolic Ca2+ signaling is a promising and novel strategy for cancer therapy.
- Further research and clinical trials are warranted to develop Ca2+-targeting cancer drugs.
More Related Videos
11:33Dissection of Local Ca2+ Signals in Cultured Cells by Membrane-targeted Ca2+ Indicators
Published on: March 22, 2019
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...